论文部分内容阅读
在2016年6月1日召开的中国科学院第十八次院士大会上,中国工程院院士、中国医学科学院院长、《中国肿瘤生物治疗杂志》主编曹雪涛教授主持的“树突状细胞与免疫调控、免疫治疗的研究”荣获陈嘉庚生命科学奖,该成果发现了树突状细胞中激活免疫功能的新分子及其调控机制,并显示出良好的应用前景。免疫学根本的科学问题是有效识别和清除病原体并保护自身稳定,树突状细胞是机体行使免疫基本功能即免疫识别与免疫应答的重要免疫细胞,曹雪涛院士研究团队与合作者对于树突状细胞的生物学特性、免疫学功能及其作用机制进行了系统和深入研究,从中发现了具有自主知识产权的免疫新分
At the eighteenth meeting of Chinese Academy of Sciences held on June 1, 2016, academicians of the Chinese Academy of Engineering, dean of the Chinese Academy of Medical Sciences and Professor Cao Xuetao, editor in chief of Chinese Journal of Cancer Biotherapy, titled Dendritic Cell and Immune Regulation , “Research on Immunotherapy” won the Tan Kah Kee Award for Life Science. The discovery of new molecules that activate immune function in dendritic cells and their regulatory mechanisms have shown promising applications. The basic scientific problem of immunology is to effectively recognize and remove pathogens and protect themselves. Dendritic cells are important immune cells that perform the basic function of immune system, that is, immune recognition and immune response. Academician Cao Xuetao’s research team and collaborators have shown that dendritic cells Biological characteristics, immunological function and its mechanism of action were systematically and in-depth study, from which found a new immune fraction with independent intellectual property rights